Skip to main content
Top
Published in: Malaria Journal 1/2008

Open Access 01-12-2008 | Research

Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria

Authors: Peter Lackner, Christian Hametner, Ronny Beer, Christoph Burger, Gregor Broessner, Raimund Helbok, Cornelia Speth, Erich Schmutzhard

Published in: Malaria Journal | Issue 1/2008

Login to get access

Abstract

Background

The patho-mechanisms leading to brain damage due to cerebral malaria (CM) are yet not fully understood. Immune-mediated and ischaemic mechanisms have been implicated. The role of complement factors C1q, C3 and C5 for the pathogenesis of CM were investigated in this study.

Methods

C57BL/6J mice were infected with Plasmodium berghei ANKA blood stages. The clinical severity of the disease was assessed by a battery of 40 standardized tests for evaluating neurological functions in mice. Brain homogenates and sera of mice with CM, infected animals without CM and non-infected control animals were analyzed for C1q, C3 and C5 up-regulation by Western blotting.

Results

Densitometric analysis of Western blots of brain homogenates yielded statistically significant differences in the levels of C1q and C5 in the analyzed groups. Correlation analysis showed a statistically significant association of C1q and C5 levels with the clinical severity of the disease. More severely affected animals showed higher levels of C1q and C5. No differences in complement levels were observed between frontal and caudal parts of the brain. Densitometric analysis of Western blot of sera yielded statistically lower levels of C1q in infected animals without CM compared to animals of the control group.

Conclusion

The current study provides direct evidence for up-regulation of complement factors C1q and C5 in the brains of animals with CM. Local complement up-regulation is a possible mechanism for brain damage in experimental cerebral malaria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schmutzhard E, Gerstenbrand F: Cerebral malaria in Tanzania. Its epidemiology, clinical symptoms and neurological long term sequelae in the light of 66 cases. Trans R Soc Trop Med Hyg. 1984, 78: 351-353. 10.1016/0035-9203(84)90118-4.CrossRefPubMed Schmutzhard E, Gerstenbrand F: Cerebral malaria in Tanzania. Its epidemiology, clinical symptoms and neurological long term sequelae in the light of 66 cases. Trans R Soc Trop Med Hyg. 1984, 78: 351-353. 10.1016/0035-9203(84)90118-4.CrossRefPubMed
2.
go back to reference Newton CR, Krishna S: Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998, 79: 1-53. 10.1016/S0163-7258(98)00008-4.CrossRefPubMed Newton CR, Krishna S: Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998, 79: 1-53. 10.1016/S0163-7258(98)00008-4.CrossRefPubMed
3.
go back to reference Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L: Regulation of Murine Cerebral Malaria Pathogenesis by CD1d-Restricted NKT Cells and the Natural Killer Complex. Immunity. 2003, 18: 391-402. 10.1016/S1074-7613(03)00052-9.CrossRefPubMed Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L: Regulation of Murine Cerebral Malaria Pathogenesis by CD1d-Restricted NKT Cells and the Natural Killer Complex. Immunity. 2003, 18: 391-402. 10.1016/S1074-7613(03)00052-9.CrossRefPubMed
4.
go back to reference Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, Van Rooijen N, Viguier M, Snounou G, Renia L: On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002, 169: 6369-6375.CrossRefPubMed Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, Van Rooijen N, Viguier M, Snounou G, Renia L: On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002, 169: 6369-6375.CrossRefPubMed
5.
go back to reference Speth C, Dierich MP, Gasque P: Neuroinvasion by pathogens: a key role of the complement system. Mol Immunol. 2002, 38: 669-679. 10.1016/S0161-5890(01)00104-3.CrossRefPubMed Speth C, Dierich MP, Gasque P: Neuroinvasion by pathogens: a key role of the complement system. Mol Immunol. 2002, 38: 669-679. 10.1016/S0161-5890(01)00104-3.CrossRefPubMed
6.
go back to reference DiScipio RG, Schraufstatter IU: The role of the complement anaphylatoxins in the recruitment of eosinophils. Int Immunopharmacol. 2007, 7: 1909-1923. 10.1016/j.intimp.2007.07.006.CrossRefPubMed DiScipio RG, Schraufstatter IU: The role of the complement anaphylatoxins in the recruitment of eosinophils. Int Immunopharmacol. 2007, 7: 1909-1923. 10.1016/j.intimp.2007.07.006.CrossRefPubMed
7.
go back to reference Williams AI, Rosen FS, Hoff R: Role of complement components in the susceptibility to Plasmodium berghei infection among inbred strains of mice. Ann Trop Med Parasitol. 1975, 69: 179-185.PubMed Williams AI, Rosen FS, Hoff R: Role of complement components in the susceptibility to Plasmodium berghei infection among inbred strains of mice. Ann Trop Med Parasitol. 1975, 69: 179-185.PubMed
8.
go back to reference Krettli AU, Nussenzweig V, Nussenzweig RS: Complement alterations in rodent malaria. Am J Trop Med Hyg. 1976, 25: 34-41.PubMed Krettli AU, Nussenzweig V, Nussenzweig RS: Complement alterations in rodent malaria. Am J Trop Med Hyg. 1976, 25: 34-41.PubMed
9.
go back to reference Farkas I, Baranyi L, Liposits ZS, Yamamoto T, Okada H: Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience. 1998, 86: 903-911. 10.1016/S0306-4522(98)00108-0.CrossRefPubMed Farkas I, Baranyi L, Liposits ZS, Yamamoto T, Okada H: Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience. 1998, 86: 903-911. 10.1016/S0306-4522(98)00108-0.CrossRefPubMed
10.
go back to reference Farkas I, Baranyi L, Takahashi M, Fukuda A, Liposits Z, Yamamoto T, Okada H: A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J Physiol. 1998, 507 (Pt 3): 679-687. 10.1111/j.1469-7793.1998.679bs.x.PubMedCentralCrossRefPubMed Farkas I, Baranyi L, Takahashi M, Fukuda A, Liposits Z, Yamamoto T, Okada H: A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J Physiol. 1998, 507 (Pt 3): 679-687. 10.1111/j.1469-7793.1998.679bs.x.PubMedCentralCrossRefPubMed
11.
go back to reference Lackner P, Burger C, Pfaller K, Heussler V, Helbok R, Morandell M, Broessner G, Tannich E, Schmutzhard E, Beer R: Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol. 2007, 33: 560-571.PubMed Lackner P, Burger C, Pfaller K, Heussler V, Helbok R, Morandell M, Broessner G, Tannich E, Schmutzhard E, Beer R: Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol. 2007, 33: 560-571.PubMed
12.
go back to reference Wiese L, Kurtzhals JA, Penkowa M: Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol. 2006, 200: 216-226.CrossRefPubMed Wiese L, Kurtzhals JA, Penkowa M: Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol. 2006, 200: 216-226.CrossRefPubMed
13.
go back to reference Medana IM, Turner GD: Human cerebral malaria and the blood-brain barrier. Int J Parasitol. 2006, 36: 555-568. 10.1016/j.ijpara.2006.02.004.CrossRefPubMed Medana IM, Turner GD: Human cerebral malaria and the blood-brain barrier. Int J Parasitol. 2006, 36: 555-568. 10.1016/j.ijpara.2006.02.004.CrossRefPubMed
14.
go back to reference Lynch NJ, Willis CL, Nolan CC, Roscher S, Fowler MJ, Weihe E, Ray DE, Schwaeble WJ: Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol. 2004, 40: 709-716. 10.1016/j.molimm.2003.08.009.CrossRefPubMed Lynch NJ, Willis CL, Nolan CC, Roscher S, Fowler MJ, Weihe E, Ray DE, Schwaeble WJ: Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol. 2004, 40: 709-716. 10.1016/j.molimm.2003.08.009.CrossRefPubMed
15.
go back to reference Medana IM, Chan-Ling T, Hunt NH: Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia. 1996, 16: 51-64. 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.0.CO;2-E.CrossRefPubMed Medana IM, Chan-Ling T, Hunt NH: Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia. 1996, 16: 51-64. 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.0.CO;2-E.CrossRefPubMed
16.
go back to reference Medana IM, Hunt NH, Chan-Ling T: Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia. 1997, 19: 91-103. 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C.CrossRefPubMed Medana IM, Hunt NH, Chan-Ling T: Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia. 1997, 19: 91-103. 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C.CrossRefPubMed
17.
go back to reference Delahaye NF, Coltel N, Puthier D, Flori L, Houlgatte R, Iraqi FA, Nguyen C, Grau GE, Rihet P: Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis. 2006, 193: 312-321. 10.1086/498579.CrossRefPubMed Delahaye NF, Coltel N, Puthier D, Flori L, Houlgatte R, Iraqi FA, Nguyen C, Grau GE, Rihet P: Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis. 2006, 193: 312-321. 10.1086/498579.CrossRefPubMed
18.
go back to reference Lu JH, Teh BK, Wang L, Wang YN, Tan YS, Lai MC, Reid KB: The classical and regulatory functions of c1q in immunity and autoimmunity. Cell Mol Immunol. 2008, 5: 9-21.PubMedCentralCrossRefPubMed Lu JH, Teh BK, Wang L, Wang YN, Tan YS, Lai MC, Reid KB: The classical and regulatory functions of c1q in immunity and autoimmunity. Cell Mol Immunol. 2008, 5: 9-21.PubMedCentralCrossRefPubMed
19.
go back to reference Lovegrove FE, Gharib SA, Patel SN, Hawkes CA, Kain KC, Liles WC: Expression Microarray Analysis Implicates Apoptosis and Interferon-Responsive Mechanisms in Susceptibility to Experimental Cerebral Malaria. Am J Pathol. 2007 Lovegrove FE, Gharib SA, Patel SN, Hawkes CA, Kain KC, Liles WC: Expression Microarray Analysis Implicates Apoptosis and Interferon-Responsive Mechanisms in Susceptibility to Experimental Cerebral Malaria. Am J Pathol. 2007
20.
go back to reference Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E: Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol. 2006, 32: 177-188. 10.1111/j.1365-2990.2006.00706.x.CrossRefPubMed Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E: Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol. 2006, 32: 177-188. 10.1111/j.1365-2990.2006.00706.x.CrossRefPubMed
21.
go back to reference Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M: Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol. 2000, 12: 1015-1023. 10.1093/intimm/12.7.1015.CrossRefPubMed Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M: Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol. 2000, 12: 1015-1023. 10.1093/intimm/12.7.1015.CrossRefPubMed
22.
go back to reference Jennings VM, Actor JK, Lal AA, Hunter RL: Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun. 1997, 65: 4883-4887.PubMedCentralPubMed Jennings VM, Actor JK, Lal AA, Hunter RL: Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun. 1997, 65: 4883-4887.PubMedCentralPubMed
23.
go back to reference Morgan BP, Gasque P: Expression of complement in the brain: role in health and disease. Immunology today. 1996, 17: 461-466. 10.1016/0167-5699(96)20028-F.CrossRefPubMed Morgan BP, Gasque P: Expression of complement in the brain: role in health and disease. Immunology today. 1996, 17: 461-466. 10.1016/0167-5699(96)20028-F.CrossRefPubMed
24.
go back to reference Bonifati DM, Kishore U: Role of complement in neurodegeneration and neuroinflammation. Mol Immunol. 2007, 44: 999-1010. 10.1016/j.molimm.2006.03.007.CrossRefPubMed Bonifati DM, Kishore U: Role of complement in neurodegeneration and neuroinflammation. Mol Immunol. 2007, 44: 999-1010. 10.1016/j.molimm.2006.03.007.CrossRefPubMed
25.
go back to reference Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P: Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am J Pathol. 2000, 157: 905-918.PubMedCentralCrossRefPubMed Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P: Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am J Pathol. 2000, 157: 905-918.PubMedCentralCrossRefPubMed
26.
go back to reference Lackner P, Beer R, Helbok R, Broessner G, Engelhardt K, Brenneis C, Schmutzhard E, Pfaller K: Scanning electron microscopy of the neuropathology of murine cerebral malaria. Malar J. 2006, 5: 116-10.1186/1475-2875-5-116.PubMedCentralCrossRefPubMed Lackner P, Beer R, Helbok R, Broessner G, Engelhardt K, Brenneis C, Schmutzhard E, Pfaller K: Scanning electron microscopy of the neuropathology of murine cerebral malaria. Malar J. 2006, 5: 116-10.1186/1475-2875-5-116.PubMedCentralCrossRefPubMed
27.
go back to reference Gasque P, Singhrao SK, Neal JW, Gotze O, Morgan BP: Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol. 1997, 150: 31-41.PubMedCentralPubMed Gasque P, Singhrao SK, Neal JW, Gotze O, Morgan BP: Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol. 1997, 150: 31-41.PubMedCentralPubMed
28.
go back to reference Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de VK, Pollitt S, Williams HM, Shiels IA, Monk PN: Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 2006, 20: 1407-1417. 10.1096/fj.05-5814com.CrossRefPubMed Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de VK, Pollitt S, Williams HM, Shiels IA, Monk PN: Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 2006, 20: 1407-1417. 10.1096/fj.05-5814com.CrossRefPubMed
29.
go back to reference Patel SN, Berghout J, Lovegrove FE, Ayi K, Conroy A, Serghides L, Min-oo G, Gowda DC, Sarma JV, Rittirsch D: C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med. 2008, 205: 1133-1143. 10.1084/jem.20072248.PubMedCentralCrossRefPubMed Patel SN, Berghout J, Lovegrove FE, Ayi K, Conroy A, Serghides L, Min-oo G, Gowda DC, Sarma JV, Rittirsch D: C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med. 2008, 205: 1133-1143. 10.1084/jem.20072248.PubMedCentralCrossRefPubMed
30.
go back to reference Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA: Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation. 1996, 20: 1-9. 10.1007/BF01487740.CrossRefPubMed Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA: Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation. 1996, 20: 1-9. 10.1007/BF01487740.CrossRefPubMed
31.
go back to reference Hartmann K, Henz BM, Kruger-Krasagakes S, Kohl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T: C3a and C5a stimulate chemotaxis of human mast cells. Blood. 1997, 89: 2863-2870.PubMed Hartmann K, Henz BM, Kruger-Krasagakes S, Kohl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T: C3a and C5a stimulate chemotaxis of human mast cells. Blood. 1997, 89: 2863-2870.PubMed
32.
go back to reference Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mecheri S: Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J Exp Med. 2008, 205: 395-408. 10.1084/jem.20071548.PubMedCentralCrossRefPubMed Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mecheri S: Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J Exp Med. 2008, 205: 395-408. 10.1084/jem.20071548.PubMedCentralCrossRefPubMed
33.
go back to reference Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF: Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999, 1: 961-968. 10.1016/S1286-4579(99)80513-9.CrossRefPubMed Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF: Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999, 1: 961-968. 10.1016/S1286-4579(99)80513-9.CrossRefPubMed
34.
go back to reference Engwerda CR, Mynott TL, Sawhney S, de Souza JB, Bickle QD, Kaye PM: Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med. 2002, 195: 1371-1377. 10.1084/jem.20020128.PubMedCentralCrossRefPubMed Engwerda CR, Mynott TL, Sawhney S, de Souza JB, Bickle QD, Kaye PM: Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med. 2002, 195: 1371-1377. 10.1084/jem.20020128.PubMedCentralCrossRefPubMed
35.
go back to reference Ma N, Harding AJ, Pamphlett R, Chaudhri G, Hunt NH: Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications. J Infect Dis. 1997, 175: 1480-1489.CrossRefPubMed Ma N, Harding AJ, Pamphlett R, Chaudhri G, Hunt NH: Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications. J Infect Dis. 1997, 175: 1480-1489.CrossRefPubMed
36.
go back to reference Adam C, Geniteau M, Gougerot-Pocidalo M, Verroust P, Lebras J, Gibert C, Morel-Maroger L: Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect Immun. 1981, 31: 530-535.PubMedCentralPubMed Adam C, Geniteau M, Gougerot-Pocidalo M, Verroust P, Lebras J, Gibert C, Morel-Maroger L: Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect Immun. 1981, 31: 530-535.PubMedCentralPubMed
37.
go back to reference Dimitrov JD, Roumenina LT, Doltchinkova VR, Vassilev TL: Iron Ions and Haeme Modulate the Binding Properties of Complement Subcomponent C1q and of Immunoglobulins. Scand J Immunol. 2007, 65: 230-239. 10.1111/j.1365-3083.2006.01893.x.CrossRefPubMed Dimitrov JD, Roumenina LT, Doltchinkova VR, Vassilev TL: Iron Ions and Haeme Modulate the Binding Properties of Complement Subcomponent C1q and of Immunoglobulins. Scand J Immunol. 2007, 65: 230-239. 10.1111/j.1365-3083.2006.01893.x.CrossRefPubMed
Metadata
Title
Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria
Authors
Peter Lackner
Christian Hametner
Ronny Beer
Christoph Burger
Gregor Broessner
Raimund Helbok
Cornelia Speth
Erich Schmutzhard
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2008
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-7-207

Other articles of this Issue 1/2008

Malaria Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.